Skip to main content

Table 4 The GATK-LODN method presented good performance in artificial tumor samples. Performance of MuTect and GATK-LODN for artificial tumor samples that had variants with diverse allelic frequencies

From: Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data

  

Artificial Tumor Samples

  

Low Frequency Variants (n = 22) VAF: 0.02 – 0.26

Intermediate Frequency Variants (n = 25) VAF: 0.5 – 0.86

High Frequency Variants (n = 25) VAF: 0.97 – 1

MuTect

Somatic Candidates

22

25

25

TP

19

25

25

FN

0

0

0

FP

3

0

0

PPV

19/22

25/25

25/25

FDR

3/22

0/25

0/25

GATK-LODN

Somatic Candidates

27

32

33

TP

17

23

23

FN

5

5

2

FP

5

7

8

PPV

17/22

23/30

23/31

FDR

5/22

7/30

8/31

  1. TP True positives, FN False negatives, FP False positives, PPV Positive Predictive Value (#TP / #FP + #TP), FDR False Discovery Rate (#FP / #FP + #TP), VAF Variant Allelic Frequency
  2. GATK results were not reported in the table since it detected more than 2200 candidates out of 22 or 25 TPs